Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast… (NCT04350398) | Clinical Trial Compass
CompletedNot Applicable
Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer
France83 participantsStarted 2017-04-20
Plain-language summary
Breast cancer is the most common women's cancer and the third leading cause of death. Advances in prevention, detection and primary treatment have improved overall survival leading to its growing acceptance as a long-term disease. Following the announcement of breast cancer, but also after primary treatment, some symptoms appear directly compromising psychic and physical spheres. Hippotherapy is an emerging specialized rehabilitation approach performed through specially trained horses by accredited health professionals. The proposed hippotherapy program offers key elements for physical, psychic and social reinforcement, complementing conventional care. The aim is to provide patients with tools to consolidate their self-awareness and thus strengthen their ability to cope with the disease.
Who can participate
Age range
18 Years – 80 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Confirmed histological diagnosis of breast cancer staging \[T1-T3, N0-N2 and M0\]
* Patient already scheduled or ongoing treatment for surgery and/or chemotherapy and/or hormone therapy and/or radiotherapy
* Having consulted a physician of the Care and Support Unit of the MIS during its health care
* WHO performance index from 0 to 2
* Able to give her informed consent in writing
* Able to complete questionnaires
* Abduction of the hip necessary and sufficient (to allow horse riding)
* Affiliated to a social security scheme
* Certificate of no contraindication issued by the physician in charge
Exclusion Criteria:
* History of malignant tumors in the last 5 years with the exception of basocellular skin carcinoma or squamous cell carcinoma
* Breast cancer as a secondary diagnosis
* Medication intake or presence of conditions associated with fatigue (e.g. chronic fatigue syndrome)
* Concomitant and uncontrolled severe degenerative or chronic disease
* History of allergic reactions to dust and/or horsehair, or asthma
* Contraindications to physical activity
* History of horseback riding or hippotherapeutic treatment during the last 6 months
* Clinically significant cognitive impairment or dementia
* Pregnancy and breastfeeding
* Majors protected by law
* Patient participating in another biomedical research or in exclusion period
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Quality of life through EORTC QLQ-C30
Timeframe: Before the beginning of the protocol; after the first 1-week session; at the end of the last session at 6 months